Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Caveolin-1 gene knockout impairs nitrergic function in mouse small intestine.

Ahmed F El-Yazbi¹, Woo-Jung Cho, Geoffrey Boddy

¹Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, 9-10 Medical Sciences Bldg., Edmonton, AB, Canada.

British Journal of Pharmacology

|June 7, 2005

Summary

Caveolin-1 absence impairs nitric oxide (NO) function in mouse small intestine smooth muscles and interstitial cells of Cajal (ICC). This impairment may be compensated by apamin-sensitive mediators.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Early prediabetes aggravates neuroinflammatory and cognitive dysfunctional responses to chlorpyrifos exposure: Possible amelioration by arachidonic acid.

European journal of pharmacology·2026

Same author

Reframing SGLT2 inhibition: Anti-inflammatory mechanisms and drug target insights emerging from EMPA-TROPISM.

The Journal of pharmacology and experimental therapeutics·2026

Same author

One destination, three routes: Tacrine-Celecoxib hybrids targeting cholinesterases, COX-2, and carbonic anhydrases in cognitive impairment linked to metabolic dysfunction.

European journal of medicinal chemistry·2026

Same author

Role of Endocannabinoid System Perturbation in Organophosphate-Mediated Metabolic Impairment and Neuroinflammation.

Basic & clinical pharmacology & toxicology·2026

Same author

Repurposing SGLT2 and DPP-4 inhibitors for mild cognitive impairment in type 2 diabetes mellitus: Insights from proteomics, target prediction and molecular docking.

British journal of pharmacology·2026

Same author

Corrigendum to "Glucagon-like peptide-1 agonists alleviate adenine-induced nephrotoxicity in rats: interaction with the renin-angiotensin system and role of NLRP-3 inflammasome, nephrin and KIM-1" [Biochem. Pharmacol. 242(P4) (2025) 117431].

Biochemical pharmacology·2025

Area of Science:

Gastroenterology
Molecular Biology
Physiology

Background:

Caveolin-1 is crucial for caveolae formation and regulates signaling molecules like nitric oxide synthase (NOS).
Nitric oxide (NO) acts as an inhibitory mediator in the mouse gut.
Caveolin-1's role in NO-mediated intestinal relaxation is not fully understood.

Purpose of the Study:

To investigate the impact of caveolin-1 absence on NO function in the mouse small intestine.
To compare NO-mediated relaxation in caveolin-1 knockout (Cav1(-/-)) mice versus control mice.

Main Methods:

Utilized caveolin-1 knockout (Cav1(-/-)) mice and genetic controls.
Performed immunohistochemical staining for caveolin-1 and NOS isoforms.
Assessed intestinal tissue relaxation responses to electrical field stimulation (EFS) and pharmacological agents.

Related Experiment Videos

Main Results:

Cav1(-/-) mice showed loss of caveolin-1 and NOS in jejunal smooth muscles and ICC.
NO-mediated relaxation was significantly reduced in Cav1(-/-) mice compared to controls.
Apamin partially restored EFS-induced relaxation in Cav1(-/-) tissues, suggesting involvement of other inhibitory pathways.

Conclusions:

Caveolin-1 gene knockout alters smooth muscle and ICC function, impairing NO-mediated relaxation in the mouse small intestine.
Apamin-sensitive mediators may compensate for the loss of NO function in Cav1(-/-) mice.
These findings highlight caveolin-1's critical role in regulating intestinal smooth muscle physiology.